APA

Swisher E. M., Lin K. K., Oza A. M., Scott C. L., Giordano H., Sun J., Konecny G. E., Coleman R. L., Tinker A. V., O'Malley D. M., Kristeleit R. S., Ma L., Bell-McGuinn K. M., Brenton J. D., Cragun J. M., Oaknin A., Ray-Coquard I., Harrell M. I., Mann E., Kaufmann S. H., Floquet A., Leary A., Harding T. C., Goble S., Maloney L., Isaacson J., Allen A. R., Rolfe L., Yelensky R., Raponi M. & McNeish I. A. (20170613). Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. : The Lancet. Oncology.

Chicago

Swisher Elizabeth M, Lin Kevin K, Oza Amit M, Scott Clare L, Giordano Heidi, Sun James, Konecny Gottfried E, Coleman Robert L, Tinker Anna V, O'Malley David M, Kristeleit Rebecca S, Ma Ling, Bell-McGuinn Katherine M, Brenton James D, Cragun Janiel M, Oaknin Ana, Ray-Coquard Isabelle, Harrell Maria I, Mann Elaina, Kaufmann Scott H, Floquet Anne, Leary Alexandra, Harding Thomas C, Goble Sandra, Maloney Lara, Isaacson Jeff, Allen Andrew R, Rolfe Lindsey, Yelensky Roman, Raponi Mitch and McNeish Iain A. 20170613. Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. : The Lancet. Oncology.

Harvard

Swisher E. M., Lin K. K., Oza A. M., Scott C. L., Giordano H., Sun J., Konecny G. E., Coleman R. L., Tinker A. V., O'Malley D. M., Kristeleit R. S., Ma L., Bell-McGuinn K. M., Brenton J. D., Cragun J. M., Oaknin A., Ray-Coquard I., Harrell M. I., Mann E., Kaufmann S. H., Floquet A., Leary A., Harding T. C., Goble S., Maloney L., Isaacson J., Allen A. R., Rolfe L., Yelensky R., Raponi M. and McNeish I. A. (20170613). Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. : The Lancet. Oncology.

MLA

Swisher Elizabeth M, Lin Kevin K, Oza Amit M, Scott Clare L, Giordano Heidi, Sun James, Konecny Gottfried E, Coleman Robert L, Tinker Anna V, O'Malley David M, Kristeleit Rebecca S, Ma Ling, Bell-McGuinn Katherine M, Brenton James D, Cragun Janiel M, Oaknin Ana, Ray-Coquard Isabelle, Harrell Maria I, Mann Elaina, Kaufmann Scott H, Floquet Anne, Leary Alexandra, Harding Thomas C, Goble Sandra, Maloney Lara, Isaacson Jeff, Allen Andrew R, Rolfe Lindsey, Yelensky Roman, Raponi Mitch and McNeish Iain A. Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. : The Lancet. Oncology. 20170613.